USANA Health Sciences Reports Third Quarter Financial Results

Go back to USANA Health Sciences Reports Third Quarter Financial Results

USANA (USNA) PT Raised to $80 at Pivotal Research

October 25, 2017 12:30 PM EDT

Pivotal Research analyst Timothy Ramey raised his price target on USANA Health Sciences Inc. (NYSE: USNA) to $80.00 (from $70.00) while maintaining a Buy rating following better-than-expected Q3 EPS on 3% sales growth with F/X not a factor for the first time in three years.

Active... More

USANA Health Sciences (USNA) Tops Q3 EPS by 6c

October 24, 2017 4:17 PM EDT

USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $0.97, $0.06 better than the analyst estimate of $0.91. Revenue for the quarter came in at $261.8 million versus the consensus estimate of $259.47 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.

... More